Bergapten inhibits airway inflammation and MRGPRX2-mediated mast cells activation by targeting NR4A1
Year: 2024
Type: article
Source: International Immunopharmacology
Language: English
Topic: Mast cells and histamine
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Awards: G1091030087, G4459780457, G5963649250
OpenAlex ID: W4392462903
